Youzhong Yuan

Researcher

UAMS

Also affiliated: University of Pittsburgh (2006–2009); Chinese Academy of Medical Sciences & Peking Union Medical College (2015); Fudan University (2001); UPMC Hillman Cancer Center (2004–2013); UPMC Montefiore (2006); Institute of Hematology & Blood Diseases Hospital (2015); State Key Laboratory of Genetic Engineering (2001); University of Pennsylvania (2008)

Faculty Researcher

15 h-index 29 pubs 963 cited

Research Areas

Biomedical Subjects

Links

ORCID Lab Website

OverviewAI-generated summary

Youzhong Yuan's research focuses on the classification and understanding of hematologic malignancies, specifically myelodysplastic syndromes and plasmablastic lymphoma. His work involves analyzing large datasets from multicenter studies to refine diagnostic criteria and characterize disease subtypes. Yuan has published on the reclassification of myelodysplastic syndrome with t(6;9)(p22;q34.1)/DEK-NUP214 as acute myeloid leukemia, examining 107 cases. He also contributed to a multi-institutional study and literature review on CD138− plasmablastic lymphoma. Yuan's scholarship metrics include an h-index of 15, with 29 total publications and 952 total citations. His recent activity indicates ongoing engagement in the field of hematopathology.

Metrics

h-index: 15
Publications: 29
Citations: 963

Selected Publications

CD138− Plasmablastic Lymphoma: A Multi-institutional Study and Review of the Literature (2022)

Archives of Pathology & Laboratory Medicine 12 citations DOI OpenAlex
Myelodysplastic syndrome with t(6;9)(p22;q34.1)/DEK-NUP214 better classified as acute myeloid leukemia? A multicenter study of 107 cases (2021)

Modern Pathology 20 citations DOI OpenAlex
Limitations of an ex vivo breast cancer model for studying the mechanism of action of the anticancer drug paclitaxel (2020)

European Journal of Pharmacology 18 citations DOI OpenAlex
The Role of Sirtuin 3 in Radiation-Induced Long-Term Persistent Liver Injury (2020)

Antioxidants 16 citations DOI OpenAlex
Carbamate derivatives of colchicine show potent activity towards primary acute lymphoblastic leukemia and primary breast cancer cells—in vitro and ex vivo study (2020)

Journal of Biochemical and Molecular Toxicology 16 citations DOI OpenAlex
Carbamate Derivatives of Colchicine Show Potent Activity toward Primary Acute Lymphoblastic Leukemia and Primary Breast Cancer Cells: <i>In Vitro</i> and <i>Ex Vivo</i> Study (2019)

The FASEB Journal 1 citation DOI OpenAlex
Identification of a novel monocytic phenotype in Classic Hodgkin Lymphoma tumor microenvironment (2019)

PLoS ONE 1 citation DOI OpenAlex
Coactivation of NF-κB and Notch signaling is sufficient to induce B-cell transformation and enables B-myeloid conversion (2019)

Blood 22 citations DOI OpenAlex
The response of phyllodes tumor of the breast to anticancer therapy: An in vitro and ex�vivo study (2019)

Oncology Letters 13 citations DOI OpenAlex
Flower isoforms promote competitive growth in cancer (2019)

Nature 151 citations DOI OpenAlex
Identification of a Novel Phenotype of Myeloid Cells in Classical Hodgkin Lymphoma (2018)

The FASEB Journal DOI OpenAlex
A rare case of visceral leishmaniasis in an immunocompetent traveler returning to the United States from Europe (2018)

PLoS neglected tropical diseases 17 citations DOI OpenAlex
Biological activity of doubly modified salinomycin analogs – Evaluation in vitro and ex vivo (2018)

European Journal of Medicinal Chemistry 35 citations DOI OpenAlex
Myeloid transformation of plasma cell myeloma: molecular evidence of clonal evolution revealed by next generation sequencing (2018)

Diagnostic Pathology 7 citations DOI OpenAlex
CD3-positive plasmablastic B-cell neoplasms: a diagnostic pitfall (2018)

Modern Pathology 48 citations DOI OpenAlex